Answer
Reported signs of tumour flare with mosunetuzumab (Lunsumio) include new or worsening pleural effusions, localised pain and swelling at lymphoma lesion sites, and tumour inflammation.
Sources for this answer
- Lunsumio 1 mg and 30 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked